Respiratory metabolomics can provide a deep understanding of all metabolic processes in the human body, studying physiological and pathological states at the metabolic level to gain a more comprehensive understanding of physical health information. From a sample dimension perspective, exhaled breath testing is gradually becoming the fourth type of testing method after blood tests, urine tests, and stool tests. As an emerging field in point-of-care (POCT) diagnostics, exhaled breath testing is currently a hot topic in the research of non-invasive clinical disease diagnosis and human metabolic monitoring due to its safety, non-invasiveness, simplicity, and convenience.
Frost & Sullivan (hereinafter referred to as 'Frost & Sullivan') has authored the 'Blue Book on the Development of China's Exhaled Breath Testing Industry' (hereinafter referred to as the 'Blue Book'), aiming to analyze the current status of the exhaled breath testing industry, track the development context of the industry and technology, tap into the huge potential for industry development, and analyze the driving factors behind market development, in order to provide a reference for participants and observers in the exhaled breath testing sector.
